Translate U.S. market and regulatory signals into the next commercialization milestone.
Weekly edition: Oct 9, 2026AI-prepared; human review pendingSources checked: Oct 9, 2026
In this edition
3 signals for your next decision
01
RecentProposed FDA guidance agenda
FDA prioritizes medical AI lifecycle and change-control guidance
What changed
FDA’s FY2027 agenda prioritizes final guidance on AI device software lifecycle management, predetermined change control plans and quality-system information for certain submissions.
Why it matters
Japanese medical-AI teams should anticipate evolving documentation and update-management expectations when planning U.S. development milestones.
Consider next
Compare the agenda with your submission calendar, monitor publication and consider comments by November 30.
Sources & context3 sources
Relevant to
Regulated medical AI, adaptive software and teams preparing U.S. device submissions
Limits to keep in mind
An agenda to finalize guidance is not issued final guidance. Priorities and publication timing may change.
Radiology AI: the requested broad 510(k) exemption was denied
What changed
A September final order confirmed FDA’s denial of a proposed partial 510(k) exemption for specified radiology detection, diagnosis, triage and notification software. The denial was issued April 1.
Why it matters
An earlier clearance does not create the broad exemption sought for subsequent products.
Consider next
Retain the applicable regulatory pathway and submission budget; assess each intended use and modification before U.S. commercialization.
Sources & context1 source
Relevant to
Radiology AI under 21 CFR 892.2060, 892.2070, 892.2080 or 892.2090
Limits to keep in mind
The order did not grant an exemption. Requirements remain product- and modification-specific; the September order became effective September 17, 2026.
OngoingRecurring annual registration window is open
Foreign manufacturers: verify FDA registration by December 31
What changed
The annual October 1–December 31 establishment-registration verification window is open. Foreign manufacturers subject to registration must designate a U.S. Agent.
Why it matters
Japanese manufacturers need an accountable owner coordinating the Japanese entity, U.S. Agent, device listings and required fee payment.
Consider next
Confirm your establishment’s obligations, reconcile device and contact information, and complete verification before December 31.
Sources & context1 source
Relevant to
Foreign device manufacturers and specification developers subject to establishment registration
Limits to keep in mind
This is an existing annual obligation, not a new 2026 policy. Registration does not confer marketing authorization; assess exemptions and establishment roles individually.
Source date: Feb 2, 2026Event / deadline: 2026-10-01 to 2026-12-31